Literature DB >> 17303691

Protein expression patterns associated with progression of chronic obstructive pulmonary disease in bronchoalveolar lavage of smokers.

Amelie Plymoth1, Claes-Göran Löfdahl, Ann Ekberg-Jansson, Magnus Dahlbäck, Per Broberg, Martyn Foster, Thomas E Fehniger, György Marko-Varga.   

Abstract

BACKGROUND: We modeled the expression of proteins in baseline bronchoalveolar lavage (BAL) samples from asymptomatic 60-year-old lifelong current smokers or healthy never-smokers, who were reevaluated after 6 to 7 years to record clinical outcome.
METHODS: Applying a technology toolbox consisting of replicate 2-dimensional gel separations, image annotation, and mass spectrometry identification, we catalogued a global set of proteins that were differentially expressed in individuals by presence, absence, and intensity scores.
RESULTS: By use of multivariate analysis, we selected a subset of proteins that accurately separated smokers from never-smokers based on composite scoring. Follow-up after 6 to 7 years identified a group of individuals who had progressed to chronic obstructive pulmonary disease (COPD), Global Initiative for Chronic Obstructive Lung Disease stage 2. The baseline BAL samples of these eventual COPD patients shared a distinct protein expression profile that could be identified using partial least-squares discriminant analysis. This pattern was not observed in BAL samples of asymptomatic smokers free of COPD at 6- to 7-year follow-up.
CONCLUSIONS: Our model suggests that certain patterns of protein expression occurring in the airways of long-term smokers may be detected in smokers susceptible to a progression of COPD disease, before disease is clinically evident.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17303691     DOI: 10.1373/clinchem.2006.076075

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  13 in total

1.  Biobank resources for future patient care: developments, principles and concepts.

Authors:  Akos Végvári; Charlotte Welinder; Henrik Lindberg; Thomas E Fehniger; György Marko-Varga
Journal:  J Clin Bioinforma       Date:  2011-09-16

2.  Bronchoalveolar lavage fluid peptidomics suggests a possible matrix metalloproteinase-3 role in bronchopulmonary dysplasia.

Authors:  Giovanni Vento; Chiara Tirone; Paola Lulli; Ettore Capoluongo; Franco Ameglio; Simona Lozzi; Francesco Cota; Fabio Mosca; Costantino Romagnoli; Irene Messana; Massimo Castagnola; Rosanna Inzitari
Journal:  Intensive Care Med       Date:  2009-09-25       Impact factor: 17.440

Review 3.  Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.

Authors:  Joanna L Richens; Richard A Urbanowicz; Elizabeth A M Lunt; Rebecca Metcalf; Jonathan Corne; Lucy Fairclough; Paul O'Shea
Journal:  Respir Res       Date:  2009-04-22

4.  Proteomic analysis of human bronchoalveolar lavage fluid after subsgemental exposure.

Authors:  Matthew W Foster; J Will Thompson; Loretta G Que; Ivana V Yang; David A Schwartz; M Arthur Moseley; Harvey E Marshall
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

5.  Characterization of the phosphoproteome in human bronchoalveolar lavage fluid.

Authors:  Francesco Giorgianni; Valentina Mileo; Dominic M Desiderio; Silvia Catinella; Sarka Beranova-Giorgianni
Journal:  Int J Proteomics       Date:  2012-09-11

6.  Proteomic analysis of whole human saliva detects enhanced expression of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 in cigarette smokers compared to non-smokers.

Authors:  Kala Jessie; Wei Wei Pang; Zubaidah Haji; Abdul Rahim; Onn Haji Hashim
Journal:  Int J Mol Sci       Date:  2010-11-09       Impact factor: 5.923

7.  Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Authors:  Marco Fumagalli; Fabio Ferrari; Maurizio Luisetti; Jan Stolk; Pieter S Hiemstra; Daniela Capuano; Simona Viglio; Laura Fregonese; Isa Cerveri; Federica Corana; Carmine Tinelli; Paolo Iadarola
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

8.  Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine.

Authors:  György Marko-Varga; Akos Végvári; Melinda Rezeli; Kaiu Prikk; Peeter Ross; Magnus Dahlbäck; Goutham Edula; Ruth Sepper; Thomas E Fehniger
Journal:  Clin Transl Med       Date:  2012-05-31

Review 9.  Application of proteomics and peptidomics to COPD.

Authors:  Girolamo Pelaia; Rosa Terracciano; Alessandro Vatrella; Luca Gallelli; Maria Teresa Busceti; Cecilia Calabrese; Cristiana Stellato; Rocco Savino; Rosario Maselli
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

10.  Susceptibility to COPD: differential proteomic profiling after acute smoking.

Authors:  Lorenza Franciosi; Dirkje S Postma; Maarten van den Berge; Natalia Govorukhina; Peter L Horvatovich; Fabrizia Fusetti; Bert Poolman; Monique E Lodewijk; Wim Timens; Rainer Bischoff; Nick H T ten Hacken
Journal:  PLoS One       Date:  2014-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.